Di Long

755 total citations
22 papers, 560 citations indexed

About

Di Long is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Di Long has authored 22 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Rheumatology and 5 papers in Molecular Biology. Recurrent topics in Di Long's work include Immune Cell Function and Interaction (7 papers), Systemic Lupus Erythematosus Research (6 papers) and T-cell and B-cell Immunology (5 papers). Di Long is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Systemic Lupus Erythematosus Research (6 papers) and T-cell and B-cell Immunology (5 papers). Di Long collaborates with scholars based in China, Hong Kong and France. Di Long's co-authors include Ming Zhao, Haijing Wu, Qianjin Lu, Yongjian Chen, Pengcheng Yu, Liwei Lu, Sen Zhang, Yaxiong Deng, Yu Feng and Chengcheng Liao and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and European Journal of Immunology.

In The Last Decade

Di Long

22 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Di Long China 11 290 140 136 93 82 22 560
Ceri A. Roberts United Kingdom 8 394 1.4× 101 0.7× 124 0.9× 100 1.1× 58 0.7× 10 614
María Jesús Citores Spain 15 292 1.0× 103 0.7× 124 0.9× 135 1.5× 46 0.6× 37 595
Tatsushi Naito Japan 10 174 0.6× 121 0.9× 72 0.5× 68 0.7× 57 0.7× 51 428
Gino Coletti Italy 13 168 0.6× 174 1.2× 154 1.1× 62 0.7× 69 0.8× 44 597
Hayley L. Eames United Kingdom 11 485 1.7× 125 0.9× 166 1.2× 94 1.0× 61 0.7× 11 670
Mitsuo Okubo Japan 13 401 1.4× 126 0.9× 97 0.7× 111 1.2× 44 0.5× 44 667
Nozomi Iwanaga Japan 12 181 0.6× 73 0.5× 158 1.2× 238 2.6× 143 1.7× 47 611
Pasquale Somma Italy 13 101 0.3× 84 0.6× 182 1.3× 82 0.9× 93 1.1× 31 458
Rudolf Peceny Germany 13 358 1.2× 108 0.8× 153 1.1× 35 0.4× 60 0.7× 20 822
Miriam Weiss United Kingdom 6 389 1.3× 107 0.8× 127 0.9× 74 0.8× 36 0.4× 6 561

Countries citing papers authored by Di Long

Since Specialization
Citations

This map shows the geographic impact of Di Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Long more than expected).

Fields of papers citing papers by Di Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Long. The network helps show where Di Long may publish in the future.

Co-authorship network of co-authors of Di Long

This figure shows the co-authorship network connecting the top 25 collaborators of Di Long. A scholar is included among the top collaborators of Di Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Long. Di Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Long, Di, et al.. (2025). 1,2,3,4-Tetrasubstituted Chiral η 6 -Benzene Ligand: Design and Application in Ruthenium-Catalyzed Asymmetric Synthesis of Tertiary Indenols via C–H Activation. Journal of the American Chemical Society. 147(47). 43707–43716. 1 indexed citations
2.
Xiong, Feng, Di Long, Weijun Peng, et al.. (2024). Quercetin ameliorates lupus symptoms by promoting the apoptosis of senescent Tfh cells via the Bcl-2 pathway. Immunity & Ageing. 21(1). 69–69. 4 indexed citations
3.
Yang, Ming, Di Long, Liting He, et al.. (2024). CD4+CD57+ senescent T cells as promoters of systemic lupus erythematosus pathogenesis and the therapeutic potential of senolytic BCL‐2 inhibitor. European Journal of Immunology. 54(7). e2350603–e2350603. 12 indexed citations
4.
Long, Di, Bingyi Yang, Ming Yang, et al.. (2023). Bach2 in CD4+ T cells from SLE patients modulates B‐cell differentiation and IgG production. European Journal of Immunology. 53(4). e2250109–e2250109. 6 indexed citations
5.
Li, Qianwen, Wei Liao, Kaili Chen, et al.. (2022). Skin CD4+ Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases. Journal of Autoimmunity. 128. 102811–102811. 17 indexed citations
6.
Wu, Haijing, Yaxiong Deng, Di Long, et al.. (2022). The IL‐21‐TET2‐AIM2‐c‐MAF pathway drives the T follicular helper cell response in lupus‐like disease. Clinical and Translational Medicine. 12(3). e781–e781. 33 indexed citations
7.
Huang, Zhong, et al.. (2022). ORLNC1 Suppresses Cell Growth in HER2-Positive Breast Cancer via miRNA-296 Sponging. Current Molecular Medicine. 23(4). 289–299. 2 indexed citations
8.
Yang, Ming, Di Long, Longyuan Hu, et al.. (2021). AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1–Bcl-6 axis-mediated B-cell differentiation. Signal Transduction and Targeted Therapy. 6(1). 341–341. 56 indexed citations
9.
Chen, Kai, Xinxin Liu, Di Long, et al.. (2021). Development and Validation of Prognostic and Diagnostic Model for Pancreatic Ductal Adenocarcinoma Based on scRNA-Seq and Bulk-Seq Datasets. SSRN Electronic Journal. 1 indexed citations
11.
Long, Di, Yongjian Chen, Haijing Wu, Ming Zhao, & Qianjin Lu. (2019). Clinical significance and immunobiology of IL-21 in autoimmunity. Journal of Autoimmunity. 99. 1–14. 148 indexed citations
12.
Huang, Zhong, et al.. (2019). BET inhibitor bromosporine enhances 5-FU effect in colorectal cancer cells. Biochemical and Biophysical Research Communications. 521(4). 840–845. 10 indexed citations
13.
Yu, Pengcheng, Di Long, Chengcheng Liao, & Sen Zhang. (2018). Association between density of tumor-infiltrating lymphocytes and prognoses of patients with gastric cancer. Medicine. 97(27). e11387–e11387. 43 indexed citations
14.
Wu, Haijing, Yaxiong Deng, Yu Feng, et al.. (2018). Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity. Cellular and Molecular Immunology. 15(7). 676–684. 94 indexed citations
15.
Liao, Ying‐Yang, Ning‐Fu Peng, Di Long, et al.. (2017). Hepatectomy for liver metastases from gastric cancer: a systematic review. BMC Surgery. 17(1). 14–14. 22 indexed citations
16.
Yu, Pengcheng, Di Long, Xiaoli Liao, et al.. (2017). Prognostic value of PD -L1 expression in patients with primary solid tumors. Oncotarget. 9(4). 5058–5072. 50 indexed citations
17.
Long, Di, Pengcheng Yu, Wei Huang, Yu-Long Luo, & Sen Zhang. (2016). Systematic review of partial hepatic resection to treat hepatic metastases in patients with gastric cancer. Medicine. 95(44). e5235–e5235. 9 indexed citations
18.
Lin, Cheng, W. Y. Lau, Di Long, et al.. (2011). Hemodynamics and oxygen transport dynamics during hepatic resection at different central venous pressures in a pig model. Hepatobiliary & pancreatic diseases international. 10(5). 516–520. 4 indexed citations
19.
Long, Di, et al.. (1991). [Postoperative analgesia for nephrectomy].. PubMed. 39(8). 533–6. 4 indexed citations
20.
Long, Di, et al.. (1984). Comparison of an enzyme-linked immunospecific assay (ELISA) with the cold complement fixation test for the serodiagnosis ofBrucella ovisinfection. New Zealand Veterinary Journal. 32(1-2). 18–20. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026